DRD2 and Tics: Although the precise etiology and pathogenesis of TD are uncertain, atypical antipsychotics that selectively block dopamine D2 receptors have been shown to be effective for the treatment of tics [7, 8] and are now the primary treatment for tics alongside behavioral interventions.